WHWK - Whitehawk Therapeutics, Inc.

QQQ $ 610.55 $ -1.07 (-0.17 %)

DIA $ 467.63 $ 1.01 (0.22 %)

SPY $ 673.03 $ 0.12 (0.02 %)

TLT $ 89.08 $ 0.09 (0.1 %)

GLD $ 375.66 $ 0.36 (0.1 %)

Previous Close

$ 2.09

Open

$ 2.12

Bid

$ 2.02 x 11

Ask

$ 2.17 x 320

Day's Range

-- - --

52 Week Range

$ 1.39 - $ 3.81

Volume

175,519

Average Volume

Market Cap

98.5M

Beta (5Y Monthly)

$ 1.55

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-06-2025	09-30-2025	10-Q
2	08-07-2025	06-30-2025	10-Q
3	05-08-2025	03-31-2025	10-Q
4	03-27-2025	12-31-2024	10-K
5	11-06-2024	09-30-2024	10-Q
6	08-07-2024	06-30-2024	10-Q
7	05-08-2024	03-31-2024	10-Q
8	03-13-2024	12-31-2023	10-K
9	11-08-2023	09-30-2023	10-Q
10	08-09-2023	06-30-2023	10-Q
11	05-10-2023	03-31-2023	10-Q
12	03-29-2023	12-31-2022	10-K
13	11-09-2022	09-30-2022	10-Q
14	08-10-2022	06-30-2022	10-Q
15	05-12-2022	03-31-2022	10-Q
16	03-17-2022	12-31-2021	10-K
17	11-10-2021	09-30-2021	10-Q
18	08-11-2021	06-30-2021	10-Q
19	05-17-2021	03-31-2021	10-Q
20	03-11-2021	12-31-2020	10-K
21	11-10-2020	09-30-2020	10-Q
22	08-12-2020	06-30-2020	10-Q
23	05-07-2020	03-31-2020	10-Q
24	03-16-2020	12-31-2019	10-K
25	11-07-2019	09-30-2019	10-Q
26	08-08-2019	06-30-2019	10-Q
27	05-09-2019	03-31-2019	10-Q
28	03-07-2019	12-31-2018	10-K
29	11-07-2018	09-30-2018	10-Q
30	08-14-2018	06-30-2018	10-Q
31	05-15-2018	03-31-2018	10-Q
32	03-15-2018	12-31-2017	10-K
33	11-13-2017	09-30-2017	10-Q
34	08-10-2017	06-30-2017	10-Q
35	05-15-2017	03-31-2017	10-Q
36	03-07-2017	12-31-2016	10-K
37	11-14-2016	09-30-2016	10-Q
38	08-15-2016	06-30-2016	10-Q
39	05-16-2016	03-31-2016	10-Q
40	03-30-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Whitehawk Therapeutics Q3 EPS $(0.26) Miss...
11/06/2025 13:37:52

Whitehawk Therapeutics (NASDAQ:WHWK) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate...

Whitehawk Therapeutics Presents Data From ...
10/24/2025 16:34:38

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK), an oncology therapeutics company applying advanced technologies to established tumo...

ionq-tempus-ai-and-aerovironment-are-among-top-10-large-cap-losers-last-week-oct-13-oct-17-are-the-others-in-your-portfolio

IonQ, Tempus AI And AeroVironment Are Amon...
10/19/2025 13:15:46

Top large-cap losers last week included IonQ, Tempus AI, AeroVironment, Astera Labs, Nebius, Kratos, F5, Klarna, Leonardo DRS, ...

whitehawk-therapeutics-dips-over-8-in-after-hours-trading-despite-new-tempus-ai-partnership

Whitehawk Therapeutics Dips Over 8% In Aft...
10/17/2025 04:44:33

Whitehawk Therapeutics announced a multi-year partnership with Tempus AI, but its stock fell 8.81% in after-hours trading follo...

12 Health Care Stocks Moving In Thursday's...
10/16/2025 17:08:00

whitehawk-therapeutics-stock-is-trading-higher-thursday-whats-going-on

Whitehawk Therapeutics Stock Is Trading Hi...
10/16/2025 15:52:45

Whitehawk Therapeutics shares are rising Thursday after the company announced a multi-year collaboration with Tempus AI to supp...

Tempus AI Enters A Multi-Year Collaboratio...
10/16/2025 12:32:44

Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a ...

Whitehawk Therapeutics Q2 EPS $(0.76) Miss...
08/07/2025 12:11:32

Whitehawk Therapeutics (NASDAQ:WHWK) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate...

Whitehawk Therapeutics Q1 EPS $1.83 Beats ...
05/08/2025 20:47:18

Whitehawk Therapeutics (NASDAQ:WHWK) reported quarterly earnings of $1.83 per share which beat the analyst consensus estimate o...

Aadi Bioscience, Now Whitehawk Therapeutic...
03/19/2025 12:55:13

Aadi Bioscience (NASDAQ:AADI) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of $(0...